• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Section Contents Menu

Transparency

Transparency Public Meeting: June 24, 2009

Overview

Transparency Report ArrowJune 24, 2009 Public Meeting

November 3, 2009 Public Meeting


Meeting Transcript

Below is a link to the complete meeting transcript from the public meeting on June 24.

PowerPoint Presentations

Meeting Agenda

8 a.m.           Welcome and Introductory Comments
                        Joshua Sharfstein, MD, Principal Deputy Commissioner
                        Afia Asamoah, JD, MPP, Special Assistant to Principal Deputy Commissioner

8:15 a.m.       Panel 1
                        Gregory Meyer, Compliance Media Inc.
                        Janet Trunzo, AdvaMed (Advanced Medical Technology Association)
                        David Lim, Independent Consultant

8:45 a.m.       Panel 2
                        Francesca T. Grifo, Ph.D., Union of Concerned Scientists
                        Jeffrey Francer, PhRMA
                        Kristi Zonno, MS, CGC, Genetic Alliance

9:15 a.m.       Panel 3
                        Steven Findlay, Consumers Union
                        Bray Patrick-Lake, Consumer
                        Allan Coukell, Pew Prescription Project

9:45 a.m.       Panel 4
                        Daniel Fabricant, Ph.D, Natural Products Association
                        Sarah Janssen, MD, Ph.D, Natural Resources Defense Council

10:15 a.m.     Break

10:30 a.m.     Panel 5
                        Bob Kelser, IDSN, Inc.
                        Kathryn Foxhall, Freelance Reporter

11:00 a.m.     Panel 6
                        Shannon Benton, The Senior Citizens League
                        Peter Lurie, MD, MPH, Public Citizen
                        Diana Zuckerman, Ph.D., Nat’l Research Center for Women & Families

11:30 a.m.     Panel 7
                        Mark B. Leahey, Medical Device Manufacturers Association
                        Nancy Beck, Ph.D., Physicians Committee for Responsible Medicine
                        Sin Hang Lee, MD, Milford Medical Laboratory

12 p.m.         Lunch

1:15 p.m.      Panel 8
                        Emily Claire Napalo, Breast Cancer Fund
                        William H. Maisel, MD, MPH, Medical Device Safety Institute
                        Andrew Emmettt, Biotechnology Industry Organization (BIO)

1:45 p.m.      Panel 9
                        Sarah Klein, The Center for Science in the Public Interest
                        Kiyo Oden, The Tatia Oden French Memorial Foundation
                        Carolyn Brubaker, Microsoft

2:15 p.m.      Break

2:30 p.m.      Open Comment Session

5 p.m.           Meeting Adjourns